Blood biomarkers are useful for the management of many diseases and
could be useful for doctors caring for stroke patients, if they accurately predicted
a diagnosis or recurrence of stroke. In a series of studies, we systematically
reviewed the blood biomarker literature in stroke, determined the performance of
existing blood biomarkers for the diagnosis of stroke and examined the value of
markers of inflammation to predict recurrent stroke and myocardial infarction.